Cost-efficient screening for BK virus in pediatric kidney transplantation: A single-center experience and review of the literature

Pediatric Transplantation

Volumn 14, Issue 5, 2010, Pages 589-595

  Laskin, B L ^a   Goebel, J ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

BK virus; costs; kidney transplantation; pediatrics; screening

Indexed keywords

ADOLESCENT; ARTICLE; BK VIRUS; CHILD; COST BENEFIT ANALYSIS; GRAFT DYSFUNCTION; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; SCHOOL CHILD; SCREENING TEST; URINALYSIS; VIRUS DETECTION;

ADOLESCENT; BK VIRUS; CHILD; COST-BENEFIT ANALYSIS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MASS SCREENING; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS;

EID: 77954479398     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01318.x     Document Type: Article

References (23)

1. Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 2009 : 87 : 621 630.
2. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007 : 22 : 1243 1250.
3. Müller A, Beck B, Theilemann K, et al. Detection of polyomavirus BK and JC in children with kidney diseases and renal transplant recipients. Pediatr Infect Dis J 2005 : 24 : 778 781.
4. Fogeda M, Muñoz P, Luque A, Morales MD, Bouza E The BKV Study Group. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients. Pediatr Transplant 2007 : 11 : 394 401.
5. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 : 75 : 1266 1270.
6. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 : 4 : 2109 2117.
7. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007 : 7 : 2727 2735.
8. Puliyanda DP, Toyoda M, Traum AZ, et al. Outcome of management strategies for BK virus replication in pediatric renal transplant recipients. Pediatr Transplant 2008 : 12 : 180 186.
9. Alexander RT, Langlois V, Tellier R, Robinson L, Hébert D. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: A single-center retrospective analysis. Pediatr Transplant 2006 : 10 : 586 592.
10. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007 : 2 : 1037 1042.
11. Kiberd BA. Screening to prevent polyoma virus nephropathy: A medical decision analysis. Am J Transplant 2005 : 5 : 2410 2416.
12. Haysom L, Rosenberg AR, Kainer G, et al. BK viral infection in an Australian pediatric renal transplant population. Pediatr Transplant 2004 : 8 : 480 484.
13. Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R. Polyomavirus infection in pediatric renal transplant recipients: Evaluation using a quantitative real-time PCR technique. Pediatr Transplant 2004 : 8 : 485 492.
14. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005 : 79 : 1277 1286.
15. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006 : 10 : 920 922.
16. Hymes LC, Greenbaum L, Amaral SG, Warshaw BL. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients. Pediatr Transplant 2007 : 11 : 536 539.
17. Dharnidharka VR, Araya CE, Wadsworth CS, McKinney MC, Howard RJ. Assessing the value of ureteral stent placement in pediatric kidney transplant recipients. Transplantation 2008 : 85 : 986 991.
18. Centers for Medicare and Medicaid Services. "Medicare Clinical Laboratory Fee Schedule." Revised January 2009. Available at http://www.cms.hhs.gov/ClinicalLabFeeSched/02-clinlab.asp#TopOfPage (accessed October 6 2009).
19. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: Applications for routine laboratory testing. Clin Microbiol Rev 2006 : 19 : 165 256.
20. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 : 347 : 488 496.
21. Goraya N, Narayanan M, Jaffers G. Biopsy proven BK polyoma nephropathy in the presence of viruria and lack of viremia [abstract]. Am J Transplant 2009 : 9 (Suppl. 2 426.
22. Smith F, Panek R, Kiberd BA. Screening to prevent polyoma virus nephropathy in kidney transplantation: A cost analysis. Am J Transplant 2009 : 9 : 2177 2179.
23. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 : 9 (Suppl. 3 S1 S157.